122 related articles for article (PubMed ID: 15317060)
1. Stereoselective synthesis of trans-threo-trans-oligopyrrolidines: potential agents for RNA cleavage.
Arndt HD; Welz R; Müller S; Ziemer B; Koert U
Chemistry; 2004 Aug; 10(16):3945-62. PubMed ID: 15317060
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective synthesis of pyrrolidine derivatives via reduction of substituted pyrroles.
Jiang C; Frontier AJ
Org Lett; 2007 Nov; 9(24):4939-42. PubMed ID: 17960937
[TBL] [Abstract][Full Text] [Related]
3. Pyrrolidine-5,5-trans-lactams. 2. The use of X-ray crystal structure data in the optimization of P3 and P4 substituents.
Andrews DM; Chaignot H; Coomber BA; Good AC; Hind SL; Johnson MR; Jones PS; Mills G; Robinson JE; Skarzynski T; Slater MJ; Somers DO
Org Lett; 2002 Dec; 4(25):4479-82. PubMed ID: 12465917
[TBL] [Abstract][Full Text] [Related]
4. Targeting the open-flap conformation of HIV-1 protease with pyrrolidine-based inhibitors.
Böttcher J; Blum A; Dörr S; Heine A; Diederich WE; Klebe G
ChemMedChem; 2008 Sep; 3(9):1337-44. PubMed ID: 18720485
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Cheng XC; Wang Q; Fang H; Tang W; Xu WF
Bioorg Med Chem; 2008 May; 16(10):5398-404. PubMed ID: 18440232
[TBL] [Abstract][Full Text] [Related]
6. Locked conformations for proline pyrrolidine ring: synthesis and conformational analysis of cis- and trans-4-tert-butylprolines.
Koskinen AM; Helaja J; Kumpulainen ET; Koivisto J; Mansikkamäki H; Rissanen K
J Org Chem; 2005 Aug; 70(16):6447-53. PubMed ID: 16050708
[TBL] [Abstract][Full Text] [Related]
7. Diastereomerically and enantiomerically pure 2,3-disubstituted pyrrolidines from 2,3-aziridin-1-ols using a sulfoxonium ylide: a one-carbon homologative relay ring expansion.
Schomaker JM; Bhattacharjee S; Yan J; Borhan B
J Am Chem Soc; 2007 Feb; 129(7):1996-2003. PubMed ID: 17256932
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective preparation of six diastereomeric quatercyclopropanes from bicyclopropylidene and some derivatives.
von Seebach M; Kozhushkov SI; Schill H; Frank D; Boese R; Benet-Buchholz J; Yufit DS; de Meijere A
Chemistry; 2007; 13(1):167-77. PubMed ID: 17024706
[TBL] [Abstract][Full Text] [Related]
9. Unexpected novel binding mode of pyrrolidine-based aspartyl protease inhibitors: design, synthesis and crystal structure in complex with HIV protease.
Specker E; Böttcher J; Brass S; Heine A; Lilie H; Schoop A; Müller G; Griebenow N; Klebe G
ChemMedChem; 2006 Jan; 1(1):106-17. PubMed ID: 16892342
[TBL] [Abstract][Full Text] [Related]
10. Asymmetric synthesis of 3-amino-4-hydroxy-2-(hydroxymethyl)pyrrolidines as potential glycosidase inhibitors.
Curtis KL; Evinson EL; Handa S; Singh K
Org Biomol Chem; 2007 Nov; 5(21):3544-53. PubMed ID: 17943217
[TBL] [Abstract][Full Text] [Related]
11. Structure-based characterization and optimization of novel hydrophobic binding interactions in a series of pyrrolidine influenza neuraminidase inhibitors.
Maring CJ; Stoll VS; Zhao C; Sun M; Krueger AC; Stewart KD; Madigan DL; Kati WM; Xu Y; Carrick RJ; Montgomery DA; Kempf-Grote A; Marsh KC; Molla A; Steffy KR; Sham HL; Laver WG; Gu YG; Kempf DJ; Kohlbrenner WE
J Med Chem; 2005 Jun; 48(12):3980-90. PubMed ID: 15943472
[TBL] [Abstract][Full Text] [Related]
12. Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidate.
Slater MJ; Amphlett EM; Andrews DM; Bravi G; Burton G; Cheasty AG; Corfield JA; Ellis MR; Fenwick RH; Fernandes S; Guidetti R; Haigh D; Hartley CD; Howes PD; Jackson DL; Jarvest RL; Lovegrove VL; Medhurst KJ; Parry NR; Price H; Shah P; Singh OM; Stocker R; Thommes P; Wilkinson C; Wonacott A
J Med Chem; 2007 Mar; 50(5):897-900. PubMed ID: 17269759
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, oxidation behavior, crystallization and structure of 2'-methylseleno guanosine containing RNAs.
Moroder H; Kreutz C; Lang K; Serganov A; Micura R
J Am Chem Soc; 2006 Aug; 128(30):9909-18. PubMed ID: 16866550
[TBL] [Abstract][Full Text] [Related]
14. Chimeric (aeg-pyrrolidine)PNAs: synthesis and stereo-discriminative duplex binding with DNA/RNA.
Lonkar PS; Ganesh KN; Kumar VA
Org Biomol Chem; 2004 Sep; 2(18):2604-11. PubMed ID: 15351824
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of a 2-aryl polyhydroxylated pyrrolidine alkaloid-based library.
Tsou EL; Chen SY; Yang MH; Wang SC; Cheng TR; Cheng WC
Bioorg Med Chem; 2008 Dec; 16(24):10198-204. PubMed ID: 19008111
[TBL] [Abstract][Full Text] [Related]
16. Convergent, stereoselective syntheses of the glycosidase inhibitors broussonetines D and M.
Ribes C; Falomir E; Murga J; Carda M; Alberto Marco J
Org Biomol Chem; 2009 Apr; 7(7):1355-60. PubMed ID: 19300820
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective ring contraction of 2,5-diketopiperazines: An innovative approach to the synthesis of promising bioactive 5-membered scaffolds.
Coursindel T; Restouin A; Dewynter G; Martinez J; Collette Y; Parrot I
Bioorg Chem; 2010 Oct; 38(5):210-7. PubMed ID: 20609458
[TBL] [Abstract][Full Text] [Related]
18. Difluoromethylenated polyhydroxylated pyrrolidines: facile synthesis, crystal structure and biological evaluation.
Wang RW; Xu J; Lopez O; Bols M; Qing FL
Future Med Chem; 2009 Aug; 1(5):991-7. PubMed ID: 21426093
[TBL] [Abstract][Full Text] [Related]
19. Complementary stereocontrolled approaches to 2-pyrrolidinones bearing a vicinal amino diol subunit with three continuous chiral centers: a formal asymmetric synthesis of (-)-detoxinine.
Zhou X; Liu WJ; Ye JL; Huang PQ
J Org Chem; 2007 Nov; 72(23):8904-9. PubMed ID: 17949109
[TBL] [Abstract][Full Text] [Related]
20. Hydrolytic cleavage of an RNA-model phosphodiester catalyzed by a highly negatively charged polyoxomolybdate [Mo7O24]6- cluster.
Absillis G; Cartuyvels E; Van Deun R; Parac-Vogt TN
J Am Chem Soc; 2008 Dec; 130(51):17400-8. PubMed ID: 19053457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
